Fig. 2: Pharmacokinetic profiles of raw plasma oxytocin concentrations over time for each treatment. | Molecular Psychiatry

Fig. 2: Pharmacokinetic profiles of raw plasma oxytocin concentrations over time for each treatment.

From: Sniffing oxytocin: Nose to brain or nose to blood?

Fig. 2

Baseline is an average of concentrations in blood samples 1 and 2. The remaining timepoints (15–90 min) correspond to blood samples 3-8. Data presented are mean ± standard error. “§” indicates significantly higher oxytocin concentrations following PLC + OXT in comparison to VC + PLC (p < 0.05 FWE corrected). “#” indicates significantly higher oxytocin concentrations following PLC + OXT in comparison to VC + OXT (p < 0.05 FWE corrected). “*” indicates significantly higher oxytocin concentrations following VC + OXT in comparison to VC + PLC (p < 0.05 FWE corrected). OXT oxytocin. VC vasoconstrictor. PLC placebo.

Back to article page